Form 4 for RANI Rani Therapeutics Holdings, Inc.
Accepted 2022-09-13 00:00:00 ET · period of report 2022-09-09 · accession 0001209191-22-049802 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-13 | 2022-09-09 | RANI | Sanford Svai S | CFO | F - Tax | $9.89 | -18.4K | 120.7K | -13% | -$181.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-09-09 | F | D | 18,362 | $9.89 | 120,738 | D | — | — | (F1) Represents the number of shares withheld by and surrendered to the Issuer on September 9, 2022, to satisfy tax withholding obligations that arose in connection with the vesting of the restricted stock units granted to Mr. Sanford on September 9, 2021. |